Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Preparation of (5.0%)Er 3+ :Y 3 Al 5 O 12 /Pt-(TiO 2 -Ta 2 O 5 ) nanocatalysts and application in sonocatalytic decomposition of ametryn in aqueous solution.

(5.0%)Er3+ :Y3 Al5 O12 /Pt-(TiO2 -Ta2 O5 ) powder, as a high effective sonocatalyst, was prepared using sol-gel and calcination method. Then it was characterized by X-ray diffractometer (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM) and energy dispersive X-ray spectroscopy (EDX). In order to evaluate the sonocatalytic activity of the prepared (5.0%)Er3+ :Y3 Al5 O12 /Pt-(TiO2 -Ta2 O5 ) powder, the sonocatalytic decomposition of ametryn was studied. In addition, some influencing factors such as different Ti/Ta molar ratios on the sonocatalytic activity of the prepared (5.0%)Er3+ :Y3 Al5 O12 /Pt-(TiO2 -Ta2 O5 ) powder, catalyst added amount with ultrasonic irradiation time and used times on the sonocatalytic decomposition efficiency were examined by using ion chromatogram determination. The experimental results showed that the best sonocatalytic decomposition ratio of ametryn were 77.50% based on the N atom calculation and 95.00% based on the S atom calculation, respectively, when the conditions of 10.00mg/L initial concentration, 1.00g/L prepared (5.0%)Er3+ :Y3 Al5 O12 /Pt-(TiO2 -Ta2 O5 ) powder (Ti/Ta=1.00:0.25 heat-treated at 550°C for 3.0h) added amount, 150min ultrasonic irradiation (40kHz frequency and 300W output power), 100mL total volume and 25-28°C temperature were adopted. Therefore, the (5.0%)Er3+ :Y3 Al5 O12 /Pt-(TiO2 -Ta2 O5 ) composite nanoparticles could be considered as an effective sonocatalyst for decomposition of ametryn in aqueous solution.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app